# Psilocybin-assisted Therapy for Alcohol Use Disorder

> **NCT06444243** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Sydney** · enrollment: 90 (estimated)

## Conditions studied

- Alcohol Use Disorder
- Alcohol Dependence
- Depression
- Anxiety

## Interventions

- **DRUG:** Psilocybin
- **DRUG:** Niacin

## Key facts

- **NCT ID:** NCT06444243
- **Lead sponsor:** University of Sydney
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09
- **Primary completion:** 2025-07
- **Final completion:** 2025-12
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06444243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06444243, "Psilocybin-assisted Therapy for Alcohol Use Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06444243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*